ARWR : Arrowhead Pharmaceuticals stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue and EPS Prognosis by Technical Analysis
| year | Average | Low | High | Change from close on 2022-12-01 |
|---|---|---|---|---|
| 2023 | $18.5 | $10.8 | $28.43 | -42.23% |
| 2024 | $6.59 | $5.01 | $9.66 | -79.43% |
| 2025 | $3.9 | $3.25 | $4.85 | -87.82% |
| 2026 | $3.65 | $3.15 | $5.26 | -88.61% |
| 2027 | $36.87 | $5.89 | $85.03 | 15.14% |
| 2028 | $95.22 | $82.56 | $116.88 | 197.37% |
| 2029 | $109.3 | $95.48 | $130.93 | 241.35% |
| 2030 | $150.57 | $133.88 | $185.28 | 370.22% |
| 2031 | $207.82 | $192.97 | $225.95 | 549.03% |
| 2032 | $249.44 | $231.87 | $264.12 | 679.02% |
The 7 Wall Street analysts offering Arrowhead Pharmaceuticals stock forecast in the last 6 months have average price target of
$58.57 with a high forecast of $110.0 and a low forecast of $33.0.
The average Arrowhead Pharmaceuticals stock forecast represents a 82.92%
increase from the last price of $32.0200004577637.
From AI system, total return is 2366.52% from 4098 forecasts.
For Arrowhead Pharmaceuticals stock forecast for 2023, 12 predictions are offered for each month of 2023 with average Arrowhead Pharmaceuticals stock
forecast of $18.5, a high forecast of $28.43, and a low forecast of $10.8.
The average Arrowhead Pharmaceuticals stock forecast 2023 represents a -42.23%
decrease from the last price of $32.0200004577637.
For Arrowhead Pharmaceuticals stock forecast for 2024, 12 predictions are offered for each month of 2024 with average Arrowhead Pharmaceuticals stock
forecast of $6.59, a high forecast of $9.66, and a low forecast of $5.01.
The average Arrowhead Pharmaceuticals stock forecast 2024 represents a -79.43%
decrease from the last price of $32.0200004577637.
For Arrowhead Pharmaceuticals stock forecast for 2026, 12 predictions are offered for each month of 2026 with average Arrowhead Pharmaceuticals stock
forecast of $3.65, a high forecast of $5.26, and a low forecast of $3.15.
The average Arrowhead Pharmaceuticals stock forecast 2026 represents a -88.61%
decrease from the last price of $32.0200004577637.
For Arrowhead Pharmaceuticals stock forecast for 2028 (5 year), 12 predictions are offered for each month of 2028 with average Arrowhead Pharmaceuticals stock
forecast of $95.22, a high forecast of $116.88, and a low forecast of $82.56.
The average Arrowhead Pharmaceuticals stock forecast 2028 represents a 197.37%
increase from the last price of $32.0200004577637.
For Arrowhead Pharmaceuticals stock forecast for 2031, 12 predictions are offered for each month of 2031 with average Arrowhead Pharmaceuticals stock
forecast of $207.82, a high forecast of $225.95, and a low forecast of $192.97.
The average Arrowhead Pharmaceuticals stock forecast 2031 represents a 549.03%
increase from the last price of $32.0200004577637.
Please, see more forecasts below.
ARWR : Arrowhead Pharmaceuticals stock forecast by Wall Street Analysts
The average Arrowhead Pharmaceuticals stock forecast from last 6 month is $58.57, and this show a 0.82% increase in average from the prior price target of the each prediction. Also, this average forecast of $58.57 represents a 3.79% increase from the past average forecast of $56.43, 6 months ago from 7 wall street analysts.
Arrowhead Pharmaceuticals stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2022-12-05 | $31.78 | -0.75% |
| 2022-12-06 | $30.83 | -2.97% |
| 2022-12-07 | $31.16 | 1.06% |
| 2022-12-08 | $31.49 | 1.05% |
| 2022-12-09 | $31.90 | 1.32% |
ARWR : Long term Arrowhead Pharmaceuticals stock forecast for 2022, 2023 (1 year) - 2025 - 2027 (5 year) - 2030, and 2032 (10 year)
Forecast for 2023 Jan. is $28.43 , for 2023 Dec. is $10.80 , for 2026 Dec. is $5.26 , for 2027 Dec. is $85.03 , for 2031 Dec. is $225.95 , and for 2032 Dec. is $264.12.
ARWR : Arrowhead Pharmaceuticals stock forecast for 2023
| Date | Price Target | Change |
|---|---|---|
| 2023 Jan. | $28.43 | -11.21% |
| 2023 Feb. | $25.73 | -9.48% |
| 2023 Mar. | $23.55 | -8.49% |
| 2023 Apr. | $21.67 | -7.97% |
| 2023 May. | $19.98 | -7.81% |
| 2023 Jun. | $18.62 | -6.80% |
| 2023 Jul. | $17.28 | -7.21% |
| 2023 Aug. | $15.89 | -8.03% |
| 2023 Sep. | $14.56 | -8.35% |
| 2023 Oct. | $13.32 | -8.52% |
| 2023 Nov. | $12.15 | -8.78% |
| 2023 Dec. | $10.80 | -11.13% |
ARWR : Arrowhead Pharmaceuticals stock forecast for 2024
| Date | Price Target | Change |
|---|---|---|
| 2024 Jan. | $9.66 | -10.57% |
| 2024 Feb. | $8.71 | -9.78% |
| 2024 Mar. | $7.94 | -8.88% |
| 2024 Apr. | $7.33 | -7.62% |
| 2024 May. | $6.79 | -7.45% |
| 2024 Jun. | $6.37 | -6.15% |
| 2024 Jul. | $5.91 | -7.18% |
| 2024 Aug. | $5.55 | -6.08% |
| 2024 Sep. | $5.35 | -3.72% |
| 2024 Oct. | $5.25 | -1.76% |
| 2024 Nov. | $5.17 | -1.56% |
| 2024 Dec. | $5.01 | -3.04% |
ARWR : Arrowhead Pharmaceuticals stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Jan. | $4.85 | -3.30% |
| 2025 Feb. | $4.66 | -3.90% |
| 2025 Mar. | $4.45 | -4.58% |
| 2025 Apr. | $4.23 | -4.81% |
| 2025 May. | $4.04 | -4.45% |
| 2025 Jun. | $3.87 | -4.18% |
| 2025 Jul. | $3.73 | -3.84% |
| 2025 Aug. | $3.59 | -3.75% |
| 2025 Sep. | $3.47 | -3.37% |
| 2025 Oct. | $3.37 | -2.79% |
| 2025 Nov. | $3.30 | -2.02% |
| 2025 Dec. | $3.25 | -1.49% |
ARWR : Arrowhead Pharmaceuticals stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $3.21 | -1.27% |
| 2026 Feb. | $3.18 | -1.08% |
| 2026 Mar. | $3.16 | -0.61% |
| 2026 Apr. | $3.15 | -0.25% |
| 2026 May. | $3.16 | 0.29% |
| 2026 Jun. | $3.19 | 1.19% |
| 2026 Jul. | $3.29 | 2.83% |
| 2026 Aug. | $3.46 | 5.41% |
| 2026 Sep. | $3.77 | 8.75% |
| 2026 Oct. | $4.21 | 11.73% |
| 2026 Nov. | $4.72 | 12.22% |
| 2026 Dec. | $5.26 | 11.46% |
ARWR : Arrowhead Pharmaceuticals stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $5.89 | 11.95% |
| 2027 Feb. | $6.73 | 14.23% |
| 2027 Mar. | $7.97 | 18.40% |
| 2027 Apr. | $9.98 | 25.24% |
| 2027 May. | $13.60 | 36.21% |
| 2027 Jun. | $20.77 | 52.80% |
| 2027 Jul. | $33.15 | 59.57% |
| 2027 Aug. | $47.44 | 43.11% |
| 2027 Sep. | $60.56 | 27.67% |
| 2027 Oct. | $71.49 | 18.04% |
| 2027 Nov. | $79.80 | 11.63% |
| 2027 Dec. | $85.03 | 6.56% |
ARWR : Arrowhead Pharmaceuticals stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $87.17 | 2.51% |
| 2028 Feb. | $85.94 | -1.41% |
| 2028 Mar. | $84.04 | -2.21% |
| 2028 Apr. | $82.85 | -1.42% |
| 2028 May. | $82.56 | -0.35% |
| 2028 Jun. | $84.25 | 2.05% |
| 2028 Jul. | $89.57 | 6.32% |
| 2028 Aug. | $97.48 | 8.83% |
| 2028 Sep. | $105.19 | 7.91% |
| 2028 Oct. | $111.29 | 5.79% |
| 2028 Nov. | $115.41 | 3.71% |
| 2028 Dec. | $116.88 | 1.27% |
ARWR : Arrowhead Pharmaceuticals stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $115.47 | -1.21% |
| 2029 Feb. | $111.86 | -3.12% |
| 2029 Mar. | $107.03 | -4.31% |
| 2029 Apr. | $101.94 | -4.76% |
| 2029 May. | $97.66 | -4.20% |
| 2029 Jun. | $95.48 | -2.23% |
| 2029 Jul. | $96.60 | 1.17% |
| 2029 Aug. | $101.52 | 5.10% |
| 2029 Sep. | $109.38 | 7.74% |
| 2029 Oct. | $118.08 | 7.95% |
| 2029 Nov. | $125.67 | 6.43% |
| 2029 Dec. | $130.93 | 4.18% |
ARWR : Arrowhead Pharmaceuticals stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $133.88 | 2.26% |
| 2030 Feb. | $135.50 | 1.21% |
| 2030 Mar. | $136.53 | 0.76% |
| 2030 Apr. | $137.49 | 0.70% |
| 2030 May. | $139.22 | 1.26% |
| 2030 Jun. | $141.91 | 1.93% |
| 2030 Jul. | $145.65 | 2.64% |
| 2030 Aug. | $150.83 | 3.55% |
| 2030 Sep. | $157.80 | 4.62% |
| 2030 Oct. | $166.53 | 5.53% |
| 2030 Nov. | $176.16 | 5.79% |
| 2030 Dec. | $185.28 | 5.18% |
ARWR : Arrowhead Pharmaceuticals stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $192.97 | 4.15% |
| 2031 Feb. | $198.60 | 2.92% |
| 2031 Mar. | $202.13 | 1.78% |
| 2031 Apr. | $204.06 | 0.95% |
| 2031 May. | $204.98 | 0.45% |
| 2031 Jun. | $205.53 | 0.27% |
| 2031 Jul. | $206.29 | 0.37% |
| 2031 Aug. | $207.82 | 0.75% |
| 2031 Sep. | $210.62 | 1.35% |
| 2031 Oct. | $214.81 | 1.99% |
| 2031 Nov. | $220.08 | 2.45% |
| 2031 Dec. | $225.95 | 2.67% |
ARWR : Arrowhead Pharmaceuticals stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $231.87 | 2.62% |
| 2032 Feb. | $237.37 | 2.37% |
| 2032 Mar. | $242.03 | 1.96% |
| 2032 Apr. | $245.62 | 1.48% |
| 2032 May. | $248.14 | 1.03% |
| 2032 Jun. | $249.81 | 0.67% |
| 2032 Jul. | $251.02 | 0.48% |
| 2032 Aug. | $252.26 | 0.50% |
| 2032 Sep. | $254.06 | 0.71% |
| 2032 Oct. | $256.75 | 1.06% |
| 2032 Nov. | $260.24 | 1.36% |
| 2032 Dec. | $264.12 | 1.49% |
Financial Data for Arrowhead Pharmaceuticals stock
Frequently Asked Questions about Arrowhead Pharmaceuticals stock forecast
Is Arrowhead Pharmaceuticals a good long term stock?
From Arrowhead Pharmaceuticals stock forecast , Arrowhead Pharmaceuticals (ARWR) stock cannot be a good investment choice. According to AI Pickup, the Arrowhead Pharmaceuticals stock price forecast for 2023 Jan. is $28.4292532777864 From Arrowhead Pharmaceuticals stock forecast , Arrowhead Pharmaceuticals (ARWR) stock cannot be a good investment choice. According to AI Pickup, the Arrowhead Pharmaceuticals stock price forecast for 2023 Dec. is $10.7998064888513 From Arrowhead Pharmaceuticals stock forecast , Arrowhead Pharmaceuticals (ARWR) stock cannot be a good investment choice. According to AI Pickup, the Arrowhead Pharmaceuticals stock price forecast for 2026 Dec. is $5.263665556992 From Arrowhead Pharmaceuticals stock forecast , Arrowhead Pharmaceuticals (ARWR) stock can be a good investment choice. According to AI Pickup, the Arrowhead Pharmaceuticals stock price forecast for 2027 Dec. is $85.0293006655364 From Arrowhead Pharmaceuticals stock forecast , Arrowhead Pharmaceuticals (ARWR) stock can be a good investment choice. According to AI Pickup, the Arrowhead Pharmaceuticals stock price forecast for 2031 Dec. is $225.948034511439 From Arrowhead Pharmaceuticals stock forecast , Arrowhead Pharmaceuticals (ARWR) stock can be a good investment choice. According to AI Pickup, the Arrowhead Pharmaceuticals stock price forecast for 2032 Dec. is $264.122696887367
Is Arrowhead Pharmaceuticals stock overvalued?
Arrowhead Pharmaceuticals (ARWR) stock is expected to go DOWN . Therefore, AI Pickup would say that Arrowhead Pharmaceuticals (ARWR) stock is overvalued.
Will Arrowhead Pharmaceuticals stock price go up?
No. The Arrowhead Pharmaceuticals stock price forecast for 2023 Dec. is $10.7998064888513
Is Arrowhead Pharmaceuticals stock a good buy now?
Since closing price on 2022-12-01 is $32.0200004577637 and forecast for 2023 Dec. is $10.80, Arrowhead Pharmaceuticals stock is not a good 1 year investment.